Literature DB >> 9338075

B-Myb: a key regulator of the cell cycle.

M K Saville1, R J Watson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9338075     DOI: 10.1016/s0065-230x(08)60701-0

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  6 in total

1.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.

Authors:  Q F Wang; J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Sequence-specific assignment of the B-Myb DNA-binding domain (B-MybR2R3) bound to a 16 base-pair DNA target site corresponding to a regulatory site from the tom-1 gene.

Authors:  Gareth Jones; Mark Howard; Pauline McIntosh; Richard A Williamson; Mark D Carr
Journal:  J Biomol NMR       Date:  2003-08       Impact factor: 2.835

4.  The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties.

Authors:  S Bergholtz; T O Andersen ; K B Andersson; J Borrebaek; B Lüscher; O S Gabrielsen
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

Review 5.  The association of mammalian DREAM complex and HPV16 E7 proteins.

Authors:  Nurshamimi Nor Rashid; Hussin A Rothan; Mohd Shahrizal Mohd Yusoff
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

Review 6.  Zebrafish cancer: the state of the art and the path forward.

Authors:  Richard White; Kristin Rose; Leonard Zon
Journal:  Nat Rev Cancer       Date:  2013-09       Impact factor: 60.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.